Synopsys Earnings Calls
| Release date | May 27, 2026 |
| EPS estimate | $3.15 |
| EPS actual | $3.35 |
| EPS Surprise | 6.35% |
| Revenue estimate | 2.251B |
| Revenue actual | 2.276B |
| Revenue Surprise | 1.12% |
| Release date | Feb 25, 2026 |
| EPS estimate | $3.56 |
| EPS actual | $3.77 |
| EPS Surprise | 5.90% |
| Revenue estimate | 2.39B |
| Revenue actual | 2.409B |
| Revenue Surprise | 0.793% |
| Release date | Dec 10, 2025 |
| EPS estimate | $2.78 |
| EPS actual | $2.90 |
| EPS Surprise | 4.32% |
| Revenue estimate | 2.247B |
| Revenue actual | 2.255B |
| Revenue Surprise | 0.334% |
| Release date | Sep 09, 2025 |
| EPS estimate | $3.80 |
| EPS actual | $3.39 |
| EPS Surprise | -10.79% |
| Revenue estimate | 1.768B |
| Revenue actual | 1.74B |
| Revenue Surprise | -1.62% |
Last 4 Quarters for Synopsys
Below you can see how SNPS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 09, 2025 |
| Price on release | $604.37 |
| EPS estimate | $3.80 |
| EPS actual | $3.39 |
| EPS surprise | -10.79% |
| Date | Price |
|---|---|
| Sep 03, 2025 | $592.12 |
| Sep 04, 2025 | $601.96 |
| Sep 05, 2025 | $598.14 |
| Sep 08, 2025 | $609.08 |
| Sep 09, 2025 | $604.37 |
| Sep 10, 2025 | $387.78 |
| Sep 11, 2025 | $438.10 |
| Sep 12, 2025 | $425.45 |
| Sep 15, 2025 | $419.20 |
| 4 days before | 2.07% |
| 4 days after | -30.64% |
| On release day | -35.84% |
| Change in period | -29.20% |
| Release date | Dec 10, 2025 |
| Price on release | $475.73 |
| EPS estimate | $2.78 |
| EPS actual | $2.90 |
| EPS surprise | 4.32% |
| Date | Price |
|---|---|
| Dec 04, 2025 | $463.74 |
| Dec 05, 2025 | $466.76 |
| Dec 08, 2025 | $465.75 |
| Dec 09, 2025 | $465.80 |
| Dec 10, 2025 | $475.73 |
| Dec 11, 2025 | $477.36 |
| Dec 12, 2025 | $452.99 |
| Dec 15, 2025 | $454.65 |
| Dec 16, 2025 | $463.34 |
| 4 days before | 2.59% |
| 4 days after | -2.60% |
| On release day | 0.343% |
| Change in period | -0.0863% |
| Release date | Feb 25, 2026 |
| Price on release | $449.17 |
| EPS estimate | $3.56 |
| EPS actual | $3.77 |
| EPS surprise | 5.90% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $442.44 |
| Feb 20, 2026 | $439.94 |
| Feb 23, 2026 | $420.82 |
| Feb 24, 2026 | $440.72 |
| Feb 25, 2026 | $449.17 |
| Feb 26, 2026 | $426.00 |
| Feb 27, 2026 | $414.00 |
| Mar 02, 2026 | $424.66 |
| Mar 03, 2026 | $424.32 |
| 4 days before | 1.52% |
| 4 days after | -5.53% |
| On release day | -5.16% |
| Change in period | -4.10% |
| Release date | May 27, 2026 |
| Price on release | $525.92 |
| EPS estimate | $3.15 |
| EPS actual | $3.35 |
| EPS surprise | 6.35% |
| Date | Price |
|---|---|
| May 20, 2026 | $498.93 |
| May 21, 2026 | $503.98 |
| May 22, 2026 | $524.74 |
| May 26, 2026 | $534.56 |
| May 27, 2026 | $525.92 |
| May 28, 2026 | $480.64 |
| May 29, 2026 | $475.62 |
| Jun 01, 2026 | $492.29 |
| Jun 02, 2026 | $508.35 |
| 4 days before | 5.41% |
| 4 days after | -3.34% |
| On release day | -8.61% |
| Change in period | 1.89% |
Synopsys Earnings Call Transcript Summary of Q2 2026
Synopsys reported a strong Q2 FY2026 with revenue of $2.276B, non-GAAP operating margin of 39.5% and non-GAAP EPS of $3.35 — all above guidance. Management raised full-year revenue, operating margin, EPS and free cash flow guidance, driven by continued AI-driven demand across EDA, IP and multiphysics simulation and by early monetization/synergy progress from the Ansys acquisition. Highlights: Design Automation/EDA showed robust demand for hardware-assisted verification, advanced-node and 3DIC flows; Multiphysics Fusion and GPU-accelerated EDA showed promising early customer results and are planned to ramp commercially in H2 2026; Design IP appears to have bottomed in Q1 and was up sequentially in Q2, with a strategic shift toward higher-value, hyperscaler-customized deals (PCIe7.0, UCIe, HBM4 momentum); Ansys integration is progressing—channel revenue recognition changed to gross, adding ~$12.5M in Q2 (and ~$60M estimated for the year) to revenue and expense (EPS-neutral); Synopsys expects to realize roughly half of committed Ansys synergies by year-end and continues disciplined cost actions while selectively hiring for priority areas. Cash flow remained strong (Q2 free cash flow ~$575M; cash & short-term investments ~$2.48B; total debt ~$10B). Share repurchases are active ($250M ASR initiated earlier, plus $50M open-market). Management reiterated confidence in long-term AI-driven growth opportunities, outlined commercialization timelines (Multiphysics Fusion and cross-Synopsys/Ansys products ramp in FY27) and scheduled an Investor Day for September 30, 2026 to provide further detail.
Sign In
Buy SNPS